Sofosbuvir for the treatment of hepatitis C virus
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.2014.857656
Reference21 articles.
1. Fibrosis and disease progression in hepatitis C
2. Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
3. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
4. Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin
5. Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities;Molecular Pharmaceutics;2023-07-24
2. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease;Advances in Kidney Disease and Health;2023-07
3. Promising Schiff bases in antiviral drug design and discovery;Medicinal Chemistry Research;2023-05-10
4. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022;International Journal of Molecular Sciences;2023-04-23
5. Natural Compounds as Non-Nucleoside Inhibitors of Zika Virus Polymerase through Integration of In Silico and In Vitro Approaches;Pharmaceuticals;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3